Omics

Is the overwhelming focus on genomics and transcriptomics in translational science really the best way to help patients?

Advances in mass spectrometry and separation science are bringing genome-scale proteomic analyses within our reach.

To select the right treatment for each cancer patient, we need fast, accurate and cost-effective ways to characterize tumors. Now, with newly developed algorithms and protocols, mate pair sequencing could well be the tool we’ve been seeking.

We’ve come a long, long way already. Where next for NGS?

Shotgun sequencing is a powerful tool in microbial genomics, but viral genomes have proven tough to crack.

Sitting Down With…John Doench, Associate Director, Genetic Perturbation Platform, Broad Institute, Cambridge, MA, USA.

From hardcore peptide biochemist to translational scientist, it’s been an unconventional journey for Jennifer Van Eyk, Director of the Advanced Clinical Biosystems Research Institute at Cedars-Sinai Medical Center, Los Angeles.

CRISPR has brought gene editing into the mainstream – but where should we draw the line?